Jan Skowroński
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jan Skowroński has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Marcin Rutka
3 shared publicationsRafał Skowroński
2 shared publications- Adrianna Błahuszewska-Omyła
Department of Rheumatology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland
1 shared publication - Andrzej Sieskiewicz
Department of Otolaryngology, Medical University of Bialystok, 15-276 Bialystok, Poland
1 shared publication - Ewa Olszewska
Department of Otolaryngology, Sleep Apnea Surgery Center, Medical University of Bialystok, 15-276 Bialystok, Poland
1 shared publication - Marek Rogowski
Department of Otolaryngology, Medical University of Bialystok, 15-276 Bialystok, Poland
1 shared publication
Latest Publications
- Open Access
- 12 January 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (2) , 245
Assessment of Lacrimal Duct Patency in Patients Undergoing Endoscopic Medial Maxillectomy
Purpose: The risk of epiphora after medial maxillectomy with lacrimal duct transection is difficult to assess. The data available in the literature are inconclusive due to various operating techniques used by the authors of medical publications, different additional procedures aimed at improving tear drainage after maxillectomy, and a variety of lacrimal duct patency assessment techniques. The aim of our work was to assess the anatomical and functional patency of lacrimal ducts after medial maxillectomy without performing additional procedures to improve tear drainage as well as comparison of the results obtained with different assessment tests. Materials and methods: 21 patients who underwent medial maxillectomy in the years 2016–2019 were assessed for discomfort and epiphora based on patients’ own reports and basic clinical examination, lacrimal duct rinse test, the Munk score, and a modified endoscopic Jones I test. Results: Gradually increasing the sensitivity of the assessment method resulted in an increase in the number of patients with potential tear drainage disorders, starting from 0% in the rinsing test, 4.8% self-reported tearing complaints, 14.3% Munk score, and 19% modified endoscopic Jones I test. Conclusions: The study results revealed that a small fraction of patients tend to report epiphora as a consequence of medial maxillectomy themselves. Subtle functional disorders, which are not particularly bothersome to patients, are more common. More sensitive lacrimal duct patency tests reveal more cases of tear drainage disorders. The results of studies assessing the incidence of epiphora after medial maxillectomy appear to depend on the type of test used.
- 12 January 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (2) , 245
Open AccessAssessment of Lacrimal Duct Patency in Patients Undergoing Endoscopic Medial Maxillectomy
Purpose: The risk of epiphora after medial maxillectomy with lacrimal duct transection is difficult to assess. The data available in the literature are inconclusive due to various operating techniques used by the authors of medical publications, different additional procedures aimed at improving tear drainage after maxillectomy, and a variety of lacrimal duct patency assessment techniques. The aim of our work was to assess the anatomical and functional patency of lacrimal ducts after medial maxillectomy without performing additional procedures to improve tear drainage as well as comparison of the results obtained with different assessment tests. Materials and methods: 21 patients who underwent medial maxillectomy in the years 2016–2019 were assessed for discomfort and epiphora based on patients’ own reports and basic clinical examination, lacrimal duct rinse test, the Munk score, and a modified endoscopic Jones I test. Results: Gradually increasing the sensitivity of the assessment method resulted in an increase in the number of patients with potential tear drainage disorders, starting from 0% in the rinsing test, 4.8% self-reported tearing complaints, 14.3% Munk score, and 19% modified endoscopic Jones I test. Conclusions: The study results revealed that a small fraction of patients tend to report epiphora as a consequence of medial maxillectomy themselves. Subtle functional disorders, which are not particularly bothersome to patients, are more common. More sensitive lacrimal duct patency tests reveal more cases of tear drainage disorders. The results of studies assessing the incidence of epiphora after medial maxillectomy appear to depend on the type of test used.
- 28 June 2013
- Published by Index Copernicus in Ortopedia Traumatologia Rehabilitacja
- Vol. 15 (3) , 1
Osteochondral lesions of the knee reconstructed with mesenchymal stem cells – results.
We present the results of the treatment of osteochondral lesions with the modified sandwich technique with a collagen membrane. The aim of the study was to assess and compare clinical outcomes following the reconstruction of osteochondral lesions in two groups of patients treated with stem cells obtained from blood and with bone marrow concentrate. The study group comprised 46 patients with MRI-confirmed osteochondral lesions of various aetiology. A group of 21 patients was treated with bone marrow concentrate and 25 patients were treated with mesenchymal cells obtained from peripheral blood. Patients were assessed with the use of KOOS, Lysholm and VAS scales at 6 months, and at 1 and 5 years following the reconstruction. We noted a significant improvement across all scales in 40 patients (86%). A poor outcome was noted in 6 patients. There was a statistically significant superiority of the group treated with stem cells obtained from blood. The analysis of MRI evidence in patients with good and excellent results showed satisfactory reconstruction of the cartilaginous surface and good regenerate integration. At 5 years, a slight decrease in mean clinical assessment scores was seen in both groups of patients. 1. The modified sandwich reconstruction is an effective modality in the treatment of severe osteochondral lesions of the knee. 2. Slightly poorer outcomes in the group treated with bone marrow concentrate may have resulted from the number of injected stem cells.
- 28 June 2013
- Published by Index Copernicus in Ortopedia Traumatologia Rehabilitacja
- Vol. 15 (3) , 1
Osteochondral lesions of the knee reconstructed with mesenchymal stem cells – results.
We present the results of the treatment of osteochondral lesions with the modified sandwich technique with a collagen membrane. The aim of the study was to assess and compare clinical outcomes following the reconstruction of osteochondral lesions in two groups of patients treated with stem cells obtained from blood and with bone marrow concentrate. The study group comprised 46 patients with MRI-confirmed osteochondral lesions of various aetiology. A group of 21 patients was treated with bone marrow concentrate and 25 patients were treated with mesenchymal cells obtained from peripheral blood. Patients were assessed with the use of KOOS, Lysholm and VAS scales at 6 months, and at 1 and 5 years following the reconstruction. We noted a significant improvement across all scales in 40 patients (86%). A poor outcome was noted in 6 patients. There was a statistically significant superiority of the group treated with stem cells obtained from blood. The analysis of MRI evidence in patients with good and excellent results showed satisfactory reconstruction of the cartilaginous surface and good regenerate integration. At 5 years, a slight decrease in mean clinical assessment scores was seen in both groups of patients. 1. The modified sandwich reconstruction is an effective modality in the treatment of severe osteochondral lesions of the knee. 2. Slightly poorer outcomes in the group treated with bone marrow concentrate may have resulted from the number of injected stem cells.
- 31 October 2012
- Published by Index Copernicus in Ortopedia Traumatologia Rehabilitacja
- Vol. 14 (5) , 1-10
Wyniki leczenia ubytków chrząstki stawu kolanowego z użyciem mezenchymalnych komórek macierzystych krwi.
The study aimed to assess long-term clinical outcomes of cartilage lesion treatment with blood stem cells. The analysis of complications of this method was an additional aim. The study group comprised 52 patients with ICRS grade III or IV lesions of 4 to 12 cm2. The assessment was carried out at one and six years following the surgery with the use of KOOS and Lysholm scales and VAS and KOOS Pain scales. No postoperative infections were reported. Poor outcomes were noted in 2 patients at 12 months following the surgery. Scores improved in across all scales with an average improvement of 23 points in the KOOS scale and 35 points in the Lysholm scale at one year. At 6 years, minor deterioration was reported in 2 more patients. 1. The reconstruction of large cartilage lesions with peripheral blood stem cells is an effective treatment modality. 2. This method is a valuable alternative to autologous chondrocyte transplantation.
- 31 October 2012
- Published by Index Copernicus in Ortopedia Traumatologia Rehabilitacja
- Vol. 14 (5) , 1-10
Wyniki leczenia ubytków chrząstki stawu kolanowego z użyciem mezenchymalnych komórek macierzystych krwi.
The study aimed to assess long-term clinical outcomes of cartilage lesion treatment with blood stem cells. The analysis of complications of this method was an additional aim. The study group comprised 52 patients with ICRS grade III or IV lesions of 4 to 12 cm2. The assessment was carried out at one and six years following the surgery with the use of KOOS and Lysholm scales and VAS and KOOS Pain scales. No postoperative infections were reported. Poor outcomes were noted in 2 patients at 12 months following the surgery. Scores improved in across all scales with an average improvement of 23 points in the KOOS scale and 35 points in the Lysholm scale at one year. At 6 years, minor deterioration was reported in 2 more patients. 1. The reconstruction of large cartilage lesions with peripheral blood stem cells is an effective treatment modality. 2. This method is a valuable alternative to autologous chondrocyte transplantation.
- 31 October 2012
- Published by Index Copernicus in Ortopedia Traumatologia Rehabilitacja
- Vol. 15 (1)
Wyniki leczenia dużych ubytków chrząstki stawu kolanowego za pomocą koncentratu komórek szpiku i membrany kolagenowej.
The study presents to assess the clinical results of cartilage lesion treatment with bone marrow concentrate and collagen membrane.
- 31 October 2012
- Published by Index Copernicus in Ortopedia Traumatologia Rehabilitacja
- Vol. 15 (1)
Wyniki leczenia dużych ubytków chrząstki stawu kolanowego za pomocą koncentratu komórek szpiku i membrany kolagenowej.
The study presents to assess the clinical results of cartilage lesion treatment with bone marrow concentrate and collagen membrane.